1. Home
  2. AZTA vs NEO Comparison

AZTA vs NEO Comparison

Compare AZTA & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$22.73

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
NEO
Founded
1978
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
AZTA
NEO
Price
$22.73
$11.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$40.60
$13.38
AVG Volume (30 Days)
1.2M
1.2M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
N/A
EPS
N/A
N/A
Revenue
$593,821,000.00
N/A
Revenue This Year
$6.99
$10.63
Revenue Next Year
$5.98
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.93
$4.72
52 Week High
$41.73
$13.74

Technical Indicators

Market Signals
Indicator
AZTA
NEO
Relative Strength Index (RSI) 56.39 72.21
Support Level $19.87 $7.50
Resistance Level $31.67 $12.60
Average True Range (ATR) 1.09 0.56
MACD 0.39 0.18
Stochastic Oscillator 75.53 96.14

Price Performance

Historical Comparison
AZTA
NEO

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: